Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Emily McDonald MD, MSc

Emily G. McDonald MD, MSc

Associate Professor of Medicine, General Internal Medicine, Research Institute, McGill University Health Centre, Montreal, Canada; Scientific Director, Canadian Medication Appropriateness and Deprescribing Network

Emily G. McDonald, MD, MSc, is a subspecialist in General Internal Medicine at the McGill University Health Centre, Associate Professor of Medicine at McGill University, and Scientist at the Research Institute of the McGill University Health Centre. She completed a Masters in Epidemiology at McGill University, post graduate research training in quality improvement and patient safety at Sunnybrook Health Sciences Centre in Toronto, Ontario, and the Program in Clinical Effectiveness at the Harvard T. H. Chan School of Public Health.

Dr. McDonald is the Associate Chair of Quality for the Department of Medicine, McGill University, and the Scientific Director of the Canadian Medication Appropriateness and Deprescribing Network. Her research focuses on drug safety and high value healthcare.


Dr. McDonald is a principal investigator on a proposal for a platform trial to test different treatments for PCP (including a low-dose TMP-SMX arm).